Integra Lifesciences Holdings Corp at JPMorgan Healthcare Conference Transcript
Welcome, everyone. I'm Robbie Marcus, the med tech analyst at JPMorgan. Very happy to introduce Integra LifeSciences' CEO, Mojdeh Poul, will give a presentation followed by some Q&A.
All right. Thank you, Robbie. I appreciate it. Good morning, everyone, and thank you for being here. I want to also thank JPMorgan for the opportunity to present here.
And my first JPMorgan conference with Integra. I've been in the role now for a year, a little over a year. So these are forward-looking statements. You can find them on our website and at your leisure, please take the time to review them. But it's a pleasure to be here to be talking about Integra.
For those of you who are not familiar with our company, we are a global med tech company. We serve highly specialized markets with differentiated portfolio that helps restore patients' lives every day. We are very well embedded within the neuro market, the neurosurgery
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
